Skip to content
10-Q

Quarterly Report

NEPHROS, INC. NEPH

0001493152-26-021701

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 10.86M sh
Shares Diluted Q1 2026 · Mar 31, 2026 10.99M sh
Shares Diluted Q1 2026 · Mar 31, 2025 10.62M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.67M
Operating Cash Flow Q1 2026 · Dec 31, 2025 $1.6M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $322K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $4.02M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $5.4M
Current Liabilities Q1 2026 · Mar 31, 2026 $2.53M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.77M
Total Liabilities Q1 2026 · Mar 31, 2026 $3.09M
Total Liabilities Q1 2026 · Dec 31, 2025 $3.44M
Current Assets Q1 2026 · Mar 31, 2026 $11.5M
Current Assets Q1 2026 · Dec 31, 2025 $11.22M
Total Assets Q1 2026 · Mar 31, 2026 $13.79M
Total Assets Q1 2026 · Dec 31, 2025 $13.64M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.01
Eps Diluted Q1 2026 · Mar 31, 2025 $0.05
Eps Basic Q1 2026 · Mar 31, 2026 $0.01
Eps Basic Q1 2026 · Mar 31, 2025 $0.05
Sga Expense Q1 2026 · Mar 31, 2026 $2.52M
Sga Expense Q1 2026 · Mar 31, 2025 $2.25M
Rd Expense Q1 2026 · Mar 31, 2026 $346K
Rd Expense Q1 2026 · Mar 31, 2025 $295K
Net Income Q1 2026 · Mar 31, 2026 $140K
Net Income Q1 2026 · Mar 31, 2025 $558K
Operating Income Q1 2026 · Mar 31, 2026 $97K
Operating Income Q1 2026 · Mar 31, 2025 $566K
Gross Profit Q1 2026 · Mar 31, 2026 $2.99M
Gross Profit Q1 2026 · Mar 31, 2025 $3.15M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $2.22M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.72M
Revenue Q1 2026 · Mar 31, 2026 $5.21M
Revenue Q1 2026 · Mar 31, 2025 $4.88M